Successful management of Epstein‑Barr virus‑associated severe checkpoint inhibitor‑related pneumonitis: A case report

A novel current treatment, immunotherapy, is normally effective for pulmonary lymphoepithelial carcinoma (pLELC). However, it is frequently accompanied by responses such as immune checkpoint inhibitor-associated pneumonitis (CIP), a rare immune adverse reaction that may be fatal in severe cases. pLE...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Jiaxi, Lin, Xinqing, Deng, Haiyi, Yang, Yilin, Guan, Wenhui, Xie, Xiaohong, Zhou, Chengzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10133792/
https://www.ncbi.nlm.nih.gov/pubmed/37123207
http://dx.doi.org/10.3892/etm.2023.11921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10133792/
https://www.ncbi.nlm.nih.gov/pubmed/37123207
http://dx.doi.org/10.3892/etm.2023.11921

Ejemplares similares